1. Home
  2. SGHT vs TMCI Comparison

SGHT vs TMCI Comparison

Compare SGHT & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$8.62

Market Cap

193.2M

Sector

Health Care

ML Signal

HOLD

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$2.86

Market Cap

174.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
TMCI
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.2M
174.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SGHT
TMCI
Price
$8.62
$2.86
Analyst Decision
Buy
Hold
Analyst Count
8
6
Target Price
$6.66
$7.07
AVG Volume (30 Days)
186.6K
807.9K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,052,000.00
$218,879,000.00
Revenue This Year
N/A
$3.25
Revenue Next Year
$12.47
$1.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.90
52 Week Low
$2.03
$2.56
52 Week High
$8.80
$10.79

Technical Indicators

Market Signals
Indicator
SGHT
TMCI
Relative Strength Index (RSI) 65.41 34.33
Support Level $8.04 $2.73
Resistance Level $8.63 $2.95
Average True Range (ATR) 0.51 0.19
MACD -0.09 0.14
Stochastic Oscillator 88.12 49.11

Price Performance

Historical Comparison
SGHT
TMCI

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: